Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography.

MLA

Hunt, Magdalena, et al. “Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography.” Journal of Diabetes Research, vol. 2022, Feb. 2022, p. 3547461. EBSCOhost, https://doi.org/10.1155/2022/3547461.

APA

Hunt, M., Teper, S., Wylęgała, A., & Wylęgała, E. (2022). Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography. Journal of Diabetes Research, 2022, 3547461. https://doi.org/10.1155/2022/3547461

Chicago

Hunt, Magdalena, Sławomir Teper, Adam Wylęgała, and Edward Wylęgała. 2022. “Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography.” Journal of Diabetes Research 2022 (February): 3547461. doi:10.1155/2022/3547461.